These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35116569)

  • 1. Narrative review of immune checkpoint inhibitors and radiation therapy for brain metastases.
    Moskalenko M; Robin TP
    Transl Cancer Res; 2021 May; 10(5):2527-2536. PubMed ID: 35116569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases.
    Koenig JL; Shi S; Sborov K; Gensheimer MF; Li G; Nagpal S; Chang SD; Gibbs IC; Soltys SG; Pollom EL
    World Neurosurg; 2019 Jun; 126():e1399-e1411. PubMed ID: 30902777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases.
    Lehrer EJ; McGee HM; Peterson JL; Vallow L; Ruiz-Garcia H; Zaorsky NG; Sharma S; Trifiletti DM
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases.
    Tonse R; Tom MC; Mehta MP; Ahluwalia MS; Kotecha R
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis.
    Tian W; Chu X; Tanzhu G; Zhou R
    J Transl Med; 2023 Apr; 21(1):244. PubMed ID: 37020242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Checkpoint Inhibitors for the Treatment of Central Nervous System (CNS) Metastatic Disease.
    Kamath SD; Kumthekar PU
    Front Oncol; 2018; 8():414. PubMed ID: 30319977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 1: Principles of Combined Treatment.
    Zhang I; Formenti SC; Knisely JPS
    Oncology (Williston Park); 2018 Feb; 32(2):e28-e32. PubMed ID: 29492951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of immuno-oncology with stereotactic radiosurgery in the management of brain metastases.
    Lehrer EJ; McGee HM; Sheehan JP; Trifiletti DM
    J Neurooncol; 2021 Jan; 151(1):75-84. PubMed ID: 32052355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and/or immunotherapy) in brain metastases: a systematic review.
    Borius PY; Régis J; Carpentier A; Kalamarides M; Valery CA; Latorzeff I
    Cancer Metastasis Rev; 2021 Mar; 40(1):341-354. PubMed ID: 33392851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited brain metastases: a narrative review.
    Chaung KV; Sloan AE; Choi S
    Ann Palliat Med; 2021 May; 10(5):6016-6027. PubMed ID: 33977758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
    Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
    J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies.
    Myall NJ; Yu H; Soltys SG; Wakelee HA; Pollom E
    Neurooncol Adv; 2021 Nov; 3(Suppl 5):v52-v62. PubMed ID: 34859233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic Radiosurgery for Treatment of Brain Metastases.
    Badiyan SN; Regine WF; Mehta M
    J Oncol Pract; 2016 Aug; 12(8):703-12. PubMed ID: 27511715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Brain Metastases in the New Era of Checkpoint Inhibition.
    Lauko A; Thapa B; Venur VA; Ahluwalia MS
    Curr Neurol Neurosci Rep; 2018 Aug; 18(10):70. PubMed ID: 30121715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy for brain metastases.
    Venur VA; Karivedu V; Ahluwalia MS
    Handb Clin Neurol; 2018; 149():137-153. PubMed ID: 29307351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of immune checkpoint inhibitors in patients with intracranial metastatic disease.
    Patel Z; Cho M; Das S
    J Neurooncol; 2023 Feb; 161(3):469-478. PubMed ID: 36790654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of the Role of Stereotactic Radiosurgery and Immunotherapy in the Management of Primary Central Nervous System Tumors.
    Lehrer EJ; Jones BM; Sindhu KK; Dickstein DR; Cohen M; Lazarev S; Quiñones-Hinojosa A; Green S; Trifiletti DM
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases.
    Moraes FY; Taunk NK; Marta GN; Suh JH; Yamada Y
    Oncologist; 2016 Feb; 21(2):244-51. PubMed ID: 26764249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies.
    Kim JM; Miller JA; Kotecha R; Xiao R; Juloori A; Ward MC; Ahluwalia MS; Mohammadi AM; Peereboom DM; Murphy ES; Suh JH; Barnett GH; Vogelbaum MA; Angelov L; Stevens GH; Chao ST
    J Neurooncol; 2017 Jun; 133(2):357-368. PubMed ID: 28434110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.